Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with type 2 diabetes mellitus and obesity: a randomized dose-ranging study
Have a BMI of 27 or Higher with Weight-Related Health Problems You could still qualify for semaglutide if you have a BMI of 27 to 29 if you have health problems caused by your weight
The medication must be prescribed by a licensed practitioner and intended for personal consumption, not resale
Both are easy to use, with once-a-week injections making it simple to stick to the treatment plan compared to taking medication every day
Lewin Z, Snow S, Lee JA, Wilkie G
In preclinical rodent studies published in ACS Chemical Biology (2023), SLU-PP-332 was found to activate an acute aerobic exercise genetic response via DDIT4 induction, increase fast oxidative skeletal muscle fibers (Type IIa), and enhance exercise endurance changes typically associated with aerobic training adaptations